The FDA may eventually pull unsafe peptides after testing and approve others, prompting big pharma to mass-produce a version that they can patent and sell
Research14 min read De Novo Peptide Design: From Computer Screen to Clinical Trial How computational peptide design transforms protein engineering from computer algorithms to clinical trials
For publications that need specific additional analytical screens (TFA residual, endotoxin, heavy metals, microplastic), FourNines is the appropriate tier
ET on the DoW SBIR/STTR Innovation Portal (DSIP): #SBIR #STTR #Innovation #SmallBusiness #DoWInnovates I confirm
When a compound has no completed human trial, there is by definition no safety data in any subgroup no pregnancy data, no hepatic-impairment data, no interaction data with common metabolic or endocrine medications
Feb 1, 2026 Your pineal gland is shrinking